Search for:
Corporate Governance

Managing Risk: Compliance in the Healthcare Sector in the Middle East

By , , and 2 Mins Read

With increased reporting of corruption in the Middle East and the desire to attract foreign direct investment, governments across the region are under pressure to align with international best practice and to further regulate and enforce. The healthcare sector is no exception, and market players may thus have to change their business practices.

Baker McKenzie Habib Al Mulla invites you to an interactive workshop in Dubai around the current market environment and emerging compliance issues for those operating in the healthcare sector in the Middle East, particularly in the UAE, Saudi Arabia and Egypt. Industry experts from Johnson & Johnson and Merck will join our lawyers in highlighting key risk areas companies should be alert to, drawing from EU and US best practices and giving practical guidance on issues such as:

  • anti-bribery trends in the healthcare sector across the region;
  • interaction with healthcare professionals (including sponsorship and fair market value); and
  • direct patient interaction and patient support programs (including data privacy, informed consent and e-health).

This workshop is FREE of charge and we hope you will be able to join us. If you have any queries, kindly contact Jenny Medina.

Date & Time

26 February 2018 | 8:30 am to 10:30 am (Gulf Standard Time)

Location

The Capital Club
Gate Village, Building 3
Dubai International Financial Centre
Dubai, UAE
View on Google Maps

 Agenda

8:30 am Registration
9:00 am Workshop
10:30 am Wrap-up

One-to-one meetings

Our lawyers will be available for one-to-one meetings in Dubai on 26 & 28 February and in Abu Dhabi on 27 February to discuss specific compliance issues you may have. Please contact UAE.BD@bakermckenzie.com if you wish to set up a personal appointment as the number of meetings will be limited.

Categories:
Author

Borys Dackiw has been a partner of Baker McKenzie since 1995. In 2008 Mr. Dackiw was appointed managing partner of the Gulf offices (including Abu Dhabi, Doha, Riyadh and Bahrain), coordinating the opening of the Abu Dhabi and Doha offices and the merger in the UAE with Habib Al Mulla in July 2013. Mr. Dackiw is head of the Compliance practice in the Gulf and also advises on mergers & acquisitions (including privatizations), private equity and general corporate and commercial law. Borys regularly advises clients across various industries on their compliance and anti-bribery policies and programs and has participated in whistleblower interviews relating to allegations of bribery and other bribery-related investigations. He also works with in house legal teams of multi-national clients to deliver tailored trainings on anti-corruption issues, including legal developments and enforcement trends in the UAE. Prior to this appointment Borys, held the position of managing partner in the Prague (Czech Republic) and Kyiv (Ukraine) offices of Baker McKenzie.

Author

Ghada El Ehwany is a counsel in Baker McKenzie Habib Al Mulla's UAE Corporate practice. Based in Dubai since 2013 and as Knowledge Manager of the UAE offices since 2014, Ghada was formerly a senior associate at Baker McKenzie’s Cairo office, Helmy, Hamza & Partners, for many years. Ghada is recognized in her field in Chambers (Egypt). She is active across a wide range of financing transactions, and was part of a team advising IFC on the financing of an expansion for Galaxy Chemicals Egypt. Ranked as "Up and Coming" in Banking & Finance and "Associates to Watch," She is also recognized by clients and peers alike for her negotiation skills and dedication to client service.

Author

Els Janssens is a Counsel in commercial law, litigation and healthcare regulatory issues in the Brussels office. Els worked as a senior regulatory legal counsel for Johnson & Johnson supporting the company's global safety operations and advising on regulatory issues in relation to specific medicinal products. Els also worked as legal advisor in the European Medicines Agency where she advised management, scientific committees, CMD(h) and the European Commission on a wide variety of issues in connection with authorisation procedures, submission requirements, pharmacovigilance obligations and procedures as well as inspections. Based in Abu Dhabi from 2014 to 2019, she advised both multinational medical devices and pharmaceutical clients on healthcare regulations in the EU and UAE.

Author

Zahi Younes is a partner in the UAE/Saudi Arabian Corporate and Securities Practice Group. He focuses on the areas of cross-border and domestic mergers and acquisitions, divestitures, international and domestic joint ventures, global corporate reorganizations, securities and capital markets. Zahi advises both private and public clients on the areas of cross-border and domestic mergers, acquisitions, divestitures, international and domestic joint ventures, private equity and global corporate reorganizations. He also counsels clients on initial public offerings, private placements and investment funds. Zahi has a regional geographic focus on the Middle East, particularly on the UAE and Saudi Arabian markets.

Related Posts